Irene A Abela,Frédérique Chammartin,Alain Amstutz,Bernard Surial,Marie Ballif,Catia Marzolini,Karoline Aebi-Popp,Julia Notter,Olivier Segeral,Marcel Stoeckle,Matthias Cavassini,Enos Bernasconi,Huldrych F Günthard,Roger D Kouyos,Chloé Pasin,
{"title":"心血管风险从低/中到高的 HIV 感染者他汀类药物处方中的性别差异。","authors":"Irene A Abela,Frédérique Chammartin,Alain Amstutz,Bernard Surial,Marie Ballif,Catia Marzolini,Karoline Aebi-Popp,Julia Notter,Olivier Segeral,Marcel Stoeckle,Matthias Cavassini,Enos Bernasconi,Huldrych F Günthard,Roger D Kouyos,Chloé Pasin,","doi":"10.1093/ofid/ofae502","DOIUrl":null,"url":null,"abstract":"The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk.\",\"authors\":\"Irene A Abela,Frédérique Chammartin,Alain Amstutz,Bernard Surial,Marie Ballif,Catia Marzolini,Karoline Aebi-Popp,Julia Notter,Olivier Segeral,Marcel Stoeckle,Matthias Cavassini,Enos Bernasconi,Huldrych F Günthard,Roger D Kouyos,Chloé Pasin,\",\"doi\":\"10.1093/ofid/ofae502\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.\",\"PeriodicalId\":19517,\"journal\":{\"name\":\"Open Forum Infectious Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2024-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Forum Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ofid/ofae502\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Forum Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ofid/ofae502","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Gender Disparities in Statin Prescriptions in People With HIV With Low/Moderate to High Cardiovascular Risk.
The REPRIEVE trial suggests that primary cardiovascular disease (CVD) prevention could be considered among people with HIV at low CVD risk. We found cisgender women with low/moderate and high CVD risk are less likely to receive statins than cisgender men. Efforts are needed to guarantee equal access to statin-based CVD prevention.
期刊介绍:
Open Forum Infectious Diseases provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment. The journal reflects the broad diversity of the field of infectious diseases, and focuses on the intersection of biomedical science and clinical practice, with a particular emphasis on knowledge that holds the potential to improve patient care in populations around the world. Fully peer-reviewed, OFID supports the international community of infectious diseases experts by providing a venue for articles that further the understanding of all aspects of infectious diseases.